Additionally, hippocampal theta-gamma PAC has also been found to be impaired in preclinical models of AD (Table 1) [123-126, 128-131, 210, 212, 215-224], which may occur before or at an early stage of tau and Aβ pathologies [124, 125, 127, 128]. Here, MAPT is linked to Alzheimer disease.